Reaction

Oesophageal Varices Haemorrhage reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,147 reports · 55 co-occurring drugs

As of the last recalculation, Oesophageal Varices Haemorrhage appears in 2,147 FAERS reports alongside 55 co-occurring drug terms. The strongest observed disproportionality signal is ATEZOLIZUMAB (PRR 61.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Atezolizumab	221	61.4	61.7
Sofosbuvir	108	55.8	56.1
Sorafenib	82	39.8	39.9
Nevirapine	28	30.5	30.6
Lenvatinib	97	30.0	30.1
Bevacizumab	290	26.1	26.1
Ribavirin	158	25.6	25.7
Ledipasvir And Sofosbuvir	49	25.3	25.3
Entecavir	30	25.2	25.3
Lactulose	83	21.8	21.8
Rifaximin	46	21.7	21.8
Lamivudine	64	20.7	20.7
Lamivudine Oral	52	20.4	20.4
Tolvaptan	30	20.3	20.3
Velpatasvir And Sofosbuvir	26	19.9	19.9
Abacavir Sulfate	19	19.1	19.1
Ursodiol	40	18.1	18.2
Tenofovir Disoproxil Fumarate Tablets	16	18.1	18.1
Zidovudine	24	17.6	17.6
Propranolol Hydrochloride	112	15.8	15.9
Efavirenz	18	15.8	15.8
Thiamine Hydrochloride	19	14.9	14.9
Spironolactone	194	14.6	14.6
Ursosiol	25	12.6	12.6
Regorafenib	13	10.9	10.9
Oxaliplatin	80	10.8	10.8
Erlotinib Hydrochloride	13	10.1	10.1
Ritonavir 100 Mg	14	9.1	9.1
Fluorouracil Cream, 0.5%	68	8.9	8.9
Atazanavir	13	8.8	8.8
Fluorouracil	68	8.8	8.8
Ritonavir	26	8.7	8.7
Panitumumab	14	8.7	8.7
Sucralfate Oral	11	7.5	7.5
Sucralfate Oral Suspension	11	7.5	7.5
Tenofovir Disoproxil Fumarate	25	7.4	7.4
Glecaprevir And Pibrentasvir	8	7.1	7.1
Ado-Trastuzumab Emtansine	6	6.9	6.9
Linagliptin	12	6.4	6.4
Trifluridine And Tipiracil	7	6.3	6.3
Erlotinib	6	6.0	6.0
Peginterferon Alfa-2A	32	5.8	5.8
Ivacaftor	4	4.9	4.9
Lumacaftor And Ivacaftor	4	4.5	4.5
Gemcitabine Hydrochloride	23	4.2	4.2
Cetuximab	13	4.0	4.0
Gemcitabine	16	4.0	4.0
Durvalumab	8	3.8	3.8
Cabozantinib	18	3.7	3.7
Emicizumab	4	3.1	3.1
Emtricitabine And Tenofovir Disoproxil Fumarate	14	3.0	3.0
Pseudoephedrine Hydrochloride	3	2.8	2.8
Pseudoephedrine Hcl	3	2.6	2.6
Methoxy Polyethylene Glycol-Epoetin Beta	3	2.6	2.6
Salicylic Acid	4	0.7	0.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.